Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Vilma Medina"'
Autor:
María Carolina Manotas, Ana Lucía Rivera, Ana Milena Gómez, Patricia Abisambra, Gonzalo Guevara, Vilma Medina, Sandra Tapiero, Antonio Huertas, Julián Riaño-Moreno, Juan Carlos Mejía, Angélica María Gonzalez-Clavijo, Mireya Tapiero-García, Andrés Arturo Cuéllar-Cuéllar, Luis Felipe Fierro-Maya, María Carolina Sanabria-Salas
Publikováno v:
Frontiers in Genetics, Vol 13 (2023)
Pheochromocytomas (PCCs) and paragangliomas (PGLs) (known as PPGL in combination) are rare neuroendocrine tumors of the adrenal medulla and extra-adrenal ganglia. About 40% of the patients with PPGL have a hereditary predisposition. Here we present a
Externí odkaz:
https://doaj.org/article/bb476b50582347ca80bb2ee962bf8546
Autor:
Handerson Rafael Osma Charris, Camilo Vallejo Yepes, Tatiana Roncancio Velandia, Carolina Bautista Saiz, Vilma Medina Boada, Fernando Contreras Mejía
Publikováno v:
Revista Colombiana de Cancerología. 24:125-134
El tumor desmoplásico de célula redonda y pequeña (TDCRP) es una patología neoplásica maligna agresiva y poco común. Afecta predominantemente a hombres entre la segunda y tercera década de la vida. Los pacientes que la padecen tienen un pobre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3f5892ad4422fde6c3358bdc84bbebf
https://doi.org/10.35509/01239015.691
https://doi.org/10.35509/01239015.691
Autor:
Jehison Alirio Herrera Pulido, Pablo Moreno Acosta, Wendy Johana Montero Ovalle, Martha Lucía Serrano López, Yenifer Yamile Segura Moreno, Alfredo Romero-Rojas, Vilma Medina Boada
Publikováno v:
Revista Colombiana de Cancerología. 25
Las alteraciones en la metilación de dinucleótidos CpG en regiones promotoras es uno de los mecanismos epigenéticos implicados en cáncer que tiene uso potencial como biomarcador. Su evaluación a partir de tejidos fijados en formalina y embebidos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f16fb3bcf782be9d6175f2007334d26d
https://doi.org/10.35509/01239015.704
https://doi.org/10.35509/01239015.704
Autor:
Yenifer Yamile Segura Moreno, Vilma Medina Boada, Rodolfo Varela Ramirez, Wendy Johana Montero Ovalle, Martha Lucía Serrano López, Jorge Mesa López de Mesa, María Carolina Sanabria-Salas
Publikováno v:
Cancer Research. 81:760-760
Prostate cancer (PCa) is the type of cancer with the highest incidence and mortality in our country. Current disease prognostic factors do not differentiate aggressive from indolent cases with sufficient certainty and for this reason, it has worked o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff3f4de17247be63a4dcc16af93d2728
https://doi.org/10.1158/1538-7445.am2021-760
https://doi.org/10.1158/1538-7445.am2021-760
Autor:
Carolina Wiesner, María Carolina Sanabria-Salas, Ana Lucía Rivera, Lina Trujillo, Antonio Huertas, Vilma Medina, Esperanza Peña, Gonzalo Guevara
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:B058-B058
Introduction: Only 4% of the submissions to CLINVAR are from Latin American countries, similarly to Latino/Hispanic representation in other population genetic databases. We don’t know the spectrum of mutations affecting Colombian families with here
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9cf840aadf31f82800fa1d3ddb23db8
https://doi.org/10.1158/1538-7755.disp19-b058
https://doi.org/10.1158/1538-7755.disp19-b058
Autor:
Carolina Wiesner-Ceballo, Gonzalo Guevara-Pardo, Jesús Acosta, Ana Lucía Rivera-Herrera, Antonio Huertas, Juan Carlos Mejía, Vilma Medina, María Carolina Sanabria-Salas
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:A049-A049
Cancer is the second cause of mortality due to noncommunicable diseases in Colombia. In 2015 incident cases of breast (BC), gastric (GC), colorectal (CRC), and ovarian cancer (OC) attended at the Colombian National Cancer Institute (NCI) were 685, 49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8efe3b42b042d73717c854f64cfcf836
https://doi.org/10.1158/1538-7755.disp18-a049
https://doi.org/10.1158/1538-7755.disp18-a049
Autor:
Carlos Gutiérrez, Sara Palma, Gustavo Kourí, Jorge Menéndez, Yilian Plasencia, Roberto Fernández, Laura Bravo, Juan Lugones, Rodrigo Valera, A. Moreno, Luis F. García, Teresita Serrano, Rafael Fando, Felicita Nuñez, Margarita Ramírez, Daniel González, Rosa L. Solís, Vilma Medina, Marlene Armesto, Domingo González, Ramón Barberá, Boris L. Rodríguez, Manuel Díaz Jidy, Hilda García, C Campa, Fernando Miralles, Juan Carlos Martínez, Aleyda Mandarioti, Francisco José Cruz Domínguez, Bárbara Cedré, Gemma Año, Gustavo Sierra, Mayelín Mirabal, Morelia Baró
Publikováno v:
Vaccine. 27:6564-6569
A randomized, double-blind, placebo-controlled clinical trial was conducted to evaluate the safety, reactogenicity and the immunogenicity of a 2 × 10 9 CFU dose of the 638 lyophilized live attenuated cholera vaccine for oral administration, formulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddcc8fbf52c31058824c3a6116ca2dac
https://doi.org/10.1016/j.vaccine.2009.08.042
https://doi.org/10.1016/j.vaccine.2009.08.042
Autor:
Vilma Medina
Publikováno v:
Medwave. 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::778f6cdbb82b302ad5f68a47faa8f6c7
https://doi.org/10.5867/medwave.2004.04.2795
https://doi.org/10.5867/medwave.2004.04.2795